World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 April 2024
Main ID:  NCT02669160
Date of registration: 27/01/2016
Prospective Registration: No
Primary sponsor: Lille Catholic University
Public title: Tolerance of a Motorized Orthosis Reproducing Walking Movement vs Conventional Standing-up Devices in Child With CP EOMEC/CP
Scientific title: Tolerance of a Motorized Orthosis Reproducing Walking Movement Versus Conventional Passive Standing-up Devices in Children With Cerebral Palsy : A Non-inferiority, Randomised, Multicenter, Controlled Trial
Date of first enrolment: November 2015
Target sample size: 25
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02669160
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Jean-François Catanzariti, MD
Address: 
Telephone:
Email:
Affiliation:  GHICL
Key inclusion & exclusion criteria

Inclusion Criteria:

- CP children from 6 to 16 years old, and being less than 150 cms, able to receive a 30
minutes verticalization session (standard practice) without sign of discomfort or
intolerance

- Communicating children

- Children who had never walked

Exclusion Criteria:

- Children presenting uncontrolled epileptic seizures

- No social insurance affiliation

- Refuse to participate in the study

- Orthopaedic surgery in 6 months which precede the inclusion.

- Injection of botulinum toxin in the 6 months which precede the inclusion.

- Previous neurotomy



Age minimum: 6 Years
Age maximum: 16 Years
Gender: All
Health Condition(s) or Problem(s) studied
CP (Cerebral Palsy)
Intervention(s)
Device: PC Innowalk
Device: Conventional passive stander
Primary Outcome(s)
Tolerance of pain according to the scale PPP (paediatric pain profile) [Time Frame: 6 weeks]
Secondary Outcome(s)
Number of days of utilization of the verticalization system until first complication or withdrawal of the study. [Time Frame: 6 weeks]
Stress evaluation measured by the change in heart rate from baseline linked to the verticalization system [Time Frame: 6 weeks]
Lower limb muscular strength measured by the Ashworth scale [Time Frame: 6 weeks]
Identification and quantification (percentage) of adverse events and complications linked to the verticalization system [Time Frame: 6 weeks]
Lower limb articular amplitudes measured by a goniometer [Time Frame: 6 weeks]
Selective motor control measured by the CMS/Boyd scale [Time Frame: 6 weeks]
Secondary ID(s)
RC-P0032
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Initiatives de parents de Jeunes Epileptiques du Nord
Région Nord-Pas de Calais, France
Unité de Traitement des Signaux Biomédicaux - HEI
Made for Movement
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history